1. Home
  2. MEI vs ALDX Comparison

MEI vs ALDX Comparison

Compare MEI & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEI
  • ALDX
  • Stock Information
  • Founded
  • MEI 1946
  • ALDX 2004
  • Country
  • MEI United States
  • ALDX United States
  • Employees
  • MEI N/A
  • ALDX N/A
  • Industry
  • MEI Electrical Products
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MEI Technology
  • ALDX Health Care
  • Exchange
  • MEI Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • MEI 256.0M
  • ALDX 296.0M
  • IPO Year
  • MEI N/A
  • ALDX 2014
  • Fundamental
  • Price
  • MEI $6.93
  • ALDX $5.06
  • Analyst Decision
  • MEI Buy
  • ALDX Strong Buy
  • Analyst Count
  • MEI 2
  • ALDX 2
  • Target Price
  • MEI $11.25
  • ALDX $9.50
  • AVG Volume (30 Days)
  • MEI 252.8K
  • ALDX 654.8K
  • Earning Date
  • MEI 12-04-2025
  • ALDX 11-05-2025
  • Dividend Yield
  • MEI 3.99%
  • ALDX N/A
  • EPS Growth
  • MEI N/A
  • ALDX N/A
  • EPS
  • MEI N/A
  • ALDX N/A
  • Revenue
  • MEI $1,030,100,000.00
  • ALDX N/A
  • Revenue This Year
  • MEI N/A
  • ALDX N/A
  • Revenue Next Year
  • MEI $3.41
  • ALDX $63.48
  • P/E Ratio
  • MEI N/A
  • ALDX N/A
  • Revenue Growth
  • MEI N/A
  • ALDX N/A
  • 52 Week Low
  • MEI $5.08
  • ALDX $1.14
  • 52 Week High
  • MEI $17.45
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • MEI 50.32
  • ALDX 46.91
  • Support Level
  • MEI $6.53
  • ALDX $4.53
  • Resistance Level
  • MEI $6.80
  • ALDX $5.35
  • Average True Range (ATR)
  • MEI 0.26
  • ALDX 0.29
  • MACD
  • MEI 0.04
  • ALDX 0.01
  • Stochastic Oscillator
  • MEI 70.05
  • ALDX 61.82

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: